Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding. [electronic resource]
- Blood Mar 2012
- 2172-4 p. digital
Publication Type: Case Reports; Letter
1528-0020
10.1182/blood-2011-11-393587 doi
Aged Benzimidazoles--adverse effects Cardiovascular Diseases--complications Dabigatran Factor VIIa--therapeutic use Humans Male Postoperative Hemorrhage--chemically induced Recombinant Proteins--therapeutic use Renal Dialysis Treatment Outcome beta-Alanine--adverse effects